Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd (KIMS) has seen its investment rating downgraded from Hold to Sell as of 22 July 2026, reflecting a complex interplay of deteriorating financial performance, challenging valuation metrics, and shifting technical indicators. Despite some long-term outperformance and strong institutional backing, the company’s recent quarterly results and technical trend changes have prompted a cautious stance from analysts.

Krishna Institute of Medical Sciences Ltd (KIMS) has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish trends. Despite a modest decline in the share price, the stock’s year-to-date returns remain robust, outperforming the Sensex by a wide margin. This article analyses the recent technical parameter changes, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of KIMS’s current market positioning.

Krishna Institute of Medical Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date perspective on its performance and outlook.

Krishna Institute of Medical Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market performance.

Surpassing its previous peak, Krishna Institute of Medical Sciences Ltd touched a new 52-week high of Rs 858.15 on 6 Jul 2026, marking a significant milestone in its price momentum. This achievement comes amid a backdrop of sustained technical strength and a market environment that has broadly supported the hospital sector.

Krishna Institute of Medical Sciences Ltd (KIMS) achieved a significant milestone on 06 Jul 2026, with its stock price reaching an all-time high of Rs.858.15. This landmark reflects the company’s sustained performance and resilience within the hospital sector, marking a notable moment in its market journey.

Krishna Institute of Medical Sciences Ltd (KIMS) achieved a significant milestone on 3 July 2026, with its stock price reaching an all-time high of Rs.851. This marks a notable moment in the company’s market journey, reflecting sustained gains and robust performance across multiple time frames.

With a decisive break above Rs 850 on 3 Jul 2026, Krishna Institute of Medical Sciences Ltd has reached a new 52-week high, marking a 25.33% gain over the past year and outpacing the Sensex’s decline of 6.32%. This milestone caps a sustained rally fuelled by strong technical momentum and consistent price appreciation over the last five trading sessions.

Surging past its previous peak, Krishna Institute of Medical Sciences Ltd touched a fresh 52-week high of Rs 846.55 on 2 Jul 2026, marking a significant milestone in its price momentum. This advance comes amid a sustained four-day rally that has delivered a 6.34% gain, outpacing the hospital sector by 1.27% today.

Krishna Institute of Medical Sciences Ltd (KIMS) achieved a significant milestone on 2 July 2026, with its stock price reaching an all-time high of Rs.842. This marks a notable moment in the company’s market journey, reflecting sustained gains and strong performance relative to its sector and benchmark indices.

With a decisive surge to Rs 840 on 1 Jul 2026, Krishna Institute of Medical Sciences Ltd has reached a fresh 52-week high, outperforming its hospital sector peers and the broader market. This milestone caps a steady rally that has seen the stock climb 20.48% over the past year, comfortably outpacing the Sensex’s decline of 8.27% during the same period.

Surging to a fresh 52-week high of Rs 831.65 on 30 Jun 2026, Krishna Institute of Medical Sciences Ltd has demonstrated robust price momentum, outpacing its hospital sector peers and the broader market over the past year.

Extending its recent gains, Krishna Institute of Medical Sciences Ltd touched a fresh all-time high of Rs 825 on 30 Jun 2026, outperforming both its sector and the broader market indices with a 2.42% rise on the day.

Krishna Institute of Medical Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 June 2026, providing investors with the latest insights into its performance and outlook.

With a near-perfect alignment of key technical indicators, Krishna Institute of Medical Sciences Ltd has surged to a fresh 52-week high of Rs 810 on 19 Jun 2026, marking a 26.08% gain over the past year and significantly outperforming the Sensex's decline of 5.78% during the same period.

Krishna Institute of Medical Sciences Ltd (KIMS) has reached a significant milestone by touching an all-time high price of Rs 812.15 on 19 June 2026, reflecting robust market momentum and sustained performance within the hospital sector.

Krishna Institute of Medical Sciences Ltd (KIMS) has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. With a price-to-earnings (P/E) ratio soaring to 127.0 and a price-to-book value (P/BV) of 14.01, investors are urged to carefully assess the stock’s price attractiveness amid these stretched multiples compared to historical and peer averages.